Advanced search
Publication Cover
Acta Oncologica Volume 58, 2019 - Issue 1
Journal homepage
1,577
Views
4
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR: MEDICAL ONCOLOGY

Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients

Anne Sofie Brems-EskildsenDepartment of Oncology, University Hospital of Aarhus, Aarhus C, Denmark; Correspondence[email protected]
,
Kristina Bak KristoffersenDepartment of Oncology, University Hospital of Aalborg, Aalborg, Denmark; Correspondence[email protected]
,
Søren LinnetDepartment of Oncology, Regional Hospital West Jutland, Herning, Denmark
,
Tamás LörinczDepartment of Oncology, University Hospital of Aalborg, Aalborg, Denmark;
&
Sven Tyge LangkjerDepartment of Oncology, University Hospital of Aarhus, Aarhus C, Denmark;
Pages 119-121 | Published online: 11 Aug 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Isabelle Chabot, Qi Zhao & Yun Su. (2020) Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer. Current Medical Research and Opinion 36:12, pages 2025-2036.
Read now
X. G. L. V. Pouwels, S. M. E. Geurts, B. L. T. Ramaekers, F. Erdkamp, B. E. P. J. Vriens, K. N. A. Aaldering, A. J. van de Wouw, M. W. Dercksen, T. J. Smilde, N. A. J. B. Peters, J. M. van Riel, M. J. Pepels, J. Heijnen-Mommers, M. A. Joore, V. C. G. Tjan-Heijnen & M. de Boer. (2020) The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry. Acta Oncologica 59:1, pages 82-89.
Read now

Articles from other publishers (2)

Yu-Ju Lin, Chun-Nan Kuo & Yu Ko. (2021) Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan. The Breast 57, pages 18-24.
Crossref
. (2019) Eribulin. Reactions Weekly 1747:1, pages 125-125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.